{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:24:44Z","timestamp":1790886284733,"version":"4.1.0"},"reference-count":54,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2025.15142","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T10:35:56Z","timestamp":1749724556000},"page":"1-17","source":"Crossref","is-referenced-by-count":6,"title":["Dosimetric comparison and prognostic analysis of helical tomotherapy vs. intensity\u2011modulated radiation therapy in locally advanced cervical cancer"],"prefix":"10.3892","volume":"30","author":[{"given":"Tao","family":"Xue","sequence":"first","affiliation":[{"name":"Department of Radiotherapy and Chemotherapy, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine, Cangzhou, Hebei 061000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Chemotherapy, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine, Cangzhou, Hebei 061000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Chemotherapy, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine, Cangzhou, Hebei 061000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Chemotherapy, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine, Cangzhou, Hebei 061000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunchuan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy and Chemotherapy, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine, Cangzhou, Hebei 061000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"key20250703131050_b1-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"key20250703131050_b2-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/ijgo.13865","article-title":"Cancer of the cervix uteri: 2021 update","volume":"155","author":"Bhatla","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"key20250703131050_b3-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/AOG.0000000000003311","article-title":"Prognostic performance of the 2018 international federation of gynecology and obstetrics cervical cancer staging guidelines","volume":"134","author":"Wright","year":"2019","journal-title":"Obstet Gynecol"},{"key":"key20250703131050_b4-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"key20250703131050_b5-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/cac2.12627","article-title":"Cancer situation in China: An analysis based on the global epidemiological data released in 2024","volume":"45","author":"Diao","year":"2024","journal-title":"Cancer Commun (Lond)"},{"key":"key20250703131050_b6-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"428.e1","DOI":"10.1016\/j.ajog.2023.06.030","article-title":"Survival associated with extent of radical hysterectomy in early-stage cervical cancer: A subanalysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study","volume":"229","author":"Bizzarri","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"key20250703131050_b7-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ygyno.2011.04.029","article-title":"New classification system of radical hysterectomy: Emphasis on a three-dimensional anatomic template for parametrial resection","volume":"122","author":"Cibula","year":"2011","journal-title":"Gynecol Oncol"},{"key":"key20250703131050_b8-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1158\/1078-0432.CCR-14-2368","article-title":"PIK3CA pathway mutations predictive of poor response following standard Radiochemotherapy \u00b1 Cetuximab in cervical cancer patients","volume":"21","author":"de la Rochefordiere","year":"2015","journal-title":"Clin Cancer Res"},{"key":"key20250703131050_b9-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ygyno.2022.08.013","article-title":"Comparison of global treatment guidelines for locally advanced cervical cancer to optimize best care practices: A systematic and scoping review","volume":"167","author":"Pujade-Lauraine","year":"2022","journal-title":"Gynecol Oncol"},{"key":"key20250703131050_b10-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.6004\/jnccn.2010.0106","article-title":"The emerging use of IMRT for treatment of cervical cancer","volume":"8","author":"Loiselle","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"key20250703131050_b11-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ijrobp.2010.09.049","article-title":"Split-field helical tomotherapy with or without chemotherapy for definitive treatment of cervical cancer","volume":"82","author":"Chang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20250703131050_b12-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.ijrobp.2004.12.029","article-title":"Intensity-modulated radiation therapy after hysterectomy: Comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size","volume":"62","author":"Ahamad","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20250703131050_b13-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijrobp.2024.07.2314","article-title":"Pelvic bone marrow sparing intensity modulated radiation therapy reduces the bone mineral density loss of patients with cervical cancer","volume":"121","author":"Huang","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20250703131050_b14-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"110648","DOI":"10.1016\/j.radonc.2024.110648","article-title":"Intensity-modulated proton therapy versus volumetric-modulated ARC therapy in patients with nasopharyngeal carcinoma: A long-term, multicenter cohort study","volume":"202","author":"Wu","year":"2025","journal-title":"Radiother Oncol"},{"key":"key20250703131050_b15-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ijrobp.2024.05.032","article-title":"Helical tomotherapy Versus 3-dimensional conformal radiation therapy in High-risk prostate cancer: A phase 3 randomized controlled trial","volume":"120","author":"Roy","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20250703131050_b16-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ijrobp.2024.03.030","article-title":"Efficacy and toxicity of moderately hypofractionated radiation therapy with helical tomotherapy versus conventional radiation therapy in patients with unresectable stage III Non-small cell lung cancer receiving concurrent chemotherapy: A multicenter, randomized phase 3 trial","volume":"120","author":"Zhang","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20250703131050_b17-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"110703","DOI":"10.1016\/j.radonc.2024.110703","article-title":"Comparison of HDR-brachytherapy and tomotherapy for the treatment of non-melanoma skin cancers of the head and neck","volume":"204","author":"Feliciani","year":"2024","journal-title":"Radiother Oncol"},{"key":"key20250703131050_b18-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.ijrobp.2005.04.011","article-title":"Comparing step-and-shoot IMRT with dynamic helical tomotherapy IMRT plans for head-and-neck cancer","volume":"62","author":"van Vulpen","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20250703131050_b19-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ijgo.12749","article-title":"Revised FIGO staging for carcinoma of the cervix uteri","volume":"145","author":"Bhatla","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"key20250703131050_b20-ol-30-2-15142","first-page":"216","article-title":"The changes in FIGO staging for carcinoma of the cervix uteri","volume":"84","author":"Sehnal","year":"2019","journal-title":"Ceska Gynekol"},{"key":"key20250703131050_b21-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"6","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"key20250703131050_b22-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ijrobp.2007.09.042","article-title":"Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer","volume":"71","author":"Small","year":"2028","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20250703131050_b23-ol-30-2-15142","article-title":"NCCN clinical practice guidelines in oncology","author":"National Comprehensive Cancer Network (NCCN)","year":"2024","journal-title":"Cervical cancer"},{"key":"key20250703131050_b24-ol-30-2-15142","first-page":"186","article-title":"Guidelines for the Treatment of Locally Advanced Cervical Cancer (2025 edition)","volume":"2","author":"Cervical Cancer Committee of China Anti-Cancer Association","year":"2025","journal-title":"Chin J Practical Gynecol Obstet"},{"key":"key20250703131050_b25-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"5359","DOI":"10.1118\/1.3238104","article-title":"IMRT commissioning: Multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119","volume":"36","author":"Ezzell","year":"2009","journal-title":"Med Phys"},{"key":"key20250703131050_b26-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"4197","DOI":"10.1118\/1.3190392","article-title":"Task Group 142 report: Quality assurance of medical accelerators","volume":"36","author":"Klein","year":"2009","journal-title":"Med Phys"},{"key":"key20250703131050_b27-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40364-021-00306-8","article-title":"Imaging biomarkers for evaluating tumor response: RECIST and beyond","volume":"9","author":"Ko","year":"2021","journal-title":"Biomark Res"},{"key":"key20250703131050_b28-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the radiation therapy oncology Group (RTOG) and the european organization for research and treatment of cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20250703131050_b29-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"e052542","DOI":"10.1136\/bmjopen-2021-052542","article-title":"Radiotherapy for head and neck tumours using an oral fixation and parameter acquisition device and TOMO technology: A randomised controlled study","volume":"11","author":"Zhang","year":"2021","journal-title":"BMJ Open"},{"key":"key20250703131050_b30-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.radonc.2007.07.012","article-title":"Tomotherapy for prostate adenocarcinoma: A report on acute toxicity","volume":"84","author":"Keiler","year":"2007","journal-title":"Radiother Oncol"},{"key":"key20250703131050_b31-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.ijrobp.2006.02.038","article-title":"Intensity-modulated radiation therapy (IMRT) dosimetry of the head and neck: A comparison of treatment plans using linear accelerator-based IMRT and helical tomotherapy","volume":"65","author":"Sheng","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20250703131050_b32-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.radonc.2008.05.010","article-title":"Dosimetric comparisons of helical tomotherapy and step-and-shoot intensity-modulated radiotherapy in nasopharyngeal carcinoma","volume":"89","author":"Lee","year":"2008","journal-title":"Radiother Oncol"},{"key":"key20250703131050_b33-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1748-717X-4-62","article-title":"Whole pelvic helical tomotherapy for locally advanced cervical cancer: Technical implementation of IMRT with helical tomotherapy","volume":"4","author":"Hsieh","year":"2009","journal-title":"Radiat Oncol"},{"key":"key20250703131050_b34-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.clon.2009.08.002","article-title":"Integral dose in three-dimensional conformal radiotherapy, intensity-modulated radiotherapy and helical tomotherapy","volume":"21","author":"Yang","year":"2009","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"key20250703131050_b35-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13014-020-1483-x","article-title":"Evaluation of plan quality and robustness of IMPT and helical IMRT for cervical cancer","volume":"15","author":"Shang","year":"2020","journal-title":"Radiat Oncol"},{"key":"key20250703131050_b36-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13014-022-02063-w","article-title":"The prognostic significance of pretreatment squamous cell carcinoma antigen levels in cervical cancer patients treated by concurrent chemoradiation therapy and a comparison of dosimetric outcomes and clinical toxicities between tomotherapy and volumetric modulated arc therapy","volume":"17","author":"Cheng","year":"2022","journal-title":"Radiat Oncol"},{"key":"key20250703131050_b37-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"110593","DOI":"10.1016\/j.radonc.2024.110593","article-title":"A feasibility study of dose-band prediction in radiation therapy: Predicting a spectrum of plan dose","volume":"202","author":"Liu","year":"2025","journal-title":"Radiother Oncol"},{"key":"key20250703131050_b38-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"1407016","DOI":"10.3389\/fonc.2024.1407016","article-title":"Improvement of accumulated dose distribution in combined cervical cancer radiotherapy with deep learning-based dose prediction","volume":"14","author":"Fu","year":"2024","journal-title":"Front Oncol"},{"key":"key20250703131050_b39-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3857\/roj.2013.31.4.252","article-title":"Dosimetric evaluation of Tomotherapy and four-box field conformal radiotherapy in locally advanced rectal cancer","volume":"31","author":"Yu","year":"2013","journal-title":"Radiat Oncol J"},{"key":"key20250703131050_b40-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13014-015-0551-0","article-title":"Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer","volume":"10","author":"Cihoric","year":"2015","journal-title":"Radiat Oncol"},{"key":"key20250703131050_b41-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.ijrobp.2008.10.017","article-title":"Preoperative helical tomotherapy and megavoltage computed tomography for rectal cancer: Impact on the irradiated volume of small bowel","volume":"74","author":"Engels","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20250703131050_b42-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ijrobp.2010.06.005","article-title":"Helical tomotherapy versus conventional intensity-modulated radiation therapy for primary chemoradiation in cervical cancer patients: An intraindividual comparison","volume":"81","author":"Marnitz","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key20250703131050_b43-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13014-022-02115-1","article-title":"Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy","volume":"17","author":"Liu","year":"2022","journal-title":"Radiat Oncol"},{"key":"key20250703131050_b44-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1097\/JS9.0000000000002098","article-title":"The prognosis of patients with locally advanced cervical cancer undergoing surgical versus non-surgical treatment: A retrospective cohort study based on SEER database and a single-center data","volume":"1","author":"Gao","year":"2025","journal-title":"Int J Surg"},{"key":"key20250703131050_b45-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3892\/ol.2022.13359","article-title":"Comparing dosimetric and cancer control outcomes after intensity-modulated radiation therapy and tomotherapy for advanced cervical cancer","volume":"24","author":"Li","year":"2022","journal-title":"Oncol Lett"},{"key":"key20250703131050_b46-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.canrad.2015.05.031","article-title":"Dosimetric comparaison between VMAT and tomotherapy with Para-aortic irradiation for cervix carcinoma","volume":"19","author":"Renard-Oldrini","year":"2015","journal-title":"Cancer Radiother"},{"key":"key20250703131050_b47-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13014-015-0398-4","article-title":"Intensity-modulated radiotherapy (IMRT) vs helical tomotherapy (HT) in concurrent chemoradiotherapy (CRT) for patients with anal canal carcinoma (ACC): An analysis of dose distribution and toxicities","volume":"10","author":"Yeung","year":"2015","journal-title":"Radiat Oncol"},{"key":"key20250703131050_b48-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.3390\/cancers14092097","article-title":"Improving patients' life quality after radiotherapy treatment by predicting late toxicities","volume":"14","author":"Lapierre","year":"2022","journal-title":"Cancers (Basel)"},{"key":"key20250703131050_b49-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.radonc.2022.04.013","article-title":"Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer-The RAPIDO trial","volume":"171","author":"Dijkstra","year":"2022","journal-title":"Radiother Oncol"},{"key":"key20250703131050_b50-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1002\/cncr.22217","article-title":"European Organization for Research and Treatment of Cancer Quality-of-Life Group: European organization for research and treatment of cancer Quality-of-Life Group: The european organization for research and treatment of cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24","volume":"107","author":"Greimel","year":"2006","journal-title":"Cancer"},{"key":"key20250703131050_b51-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/1477-7525-10-124","article-title":"Psychometric properties of the Chinese version of the Functional Assessment of Cancer Therapy-Cervix (FACT-Cx) measuring health-related quality of life","volume":"10","author":"Ding","year":"2012","journal-title":"Health Qual Life Outcomes"},{"key":"key20250703131050_b52-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1007\/s00066-019-01477-y","article-title":"Risk-adapted moderate hypofractionation of prostate cancer: A prospective analysis of acute toxicity, QOL and outcome in 221 patients","volume":"10","author":"Sch\u00f6rghofer","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"key20250703131050_b53-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1470-2045(20)30581-7","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): Patient-reported quality-of-life outcomes of a randomised, controlled, Non-inferiority, phase 3 trial","volume":"22","author":"Fransson","year":"2021","journal-title":"Lancet Oncol"},{"key":"key20250703131050_b54-ol-30-2-15142","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/annonc\/mdw617","article-title":"Does severe toxicity affect global quality of life in patients with metastatic colorectal cancer during palliative systemic treatment? A systematic review","volume":"28","author":"Schuurhuizen","year":"2017","journal-title":"Ann Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:10:59Z","timestamp":1751537459000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2025.15142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":54,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6,12]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2025.15142","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]}}}